Gil Blum
Stock Analyst at Needham
(1.94)
# 2,911
Out of 4,829 analysts
376
Total ratings
32.87%
Success rate
-9.09%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Gil Blum
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RNAC Cartesian Therapeutics | Maintains: Buy | $41 → $40 | $9.91 | +303.84% | 15 | May 8, 2025 | |
| CRSP CRISPR Therapeutics AG | Maintains: Buy | $84 → $81 | $35.62 | +127.40% | 21 | May 7, 2025 | |
| CELC Celcuity | Reiterates: Buy | $29 | $10.15 | +185.71% | 15 | Apr 11, 2025 | |
| AUTL Autolus Therapeutics | Reiterates: Buy | $10 | $1.32 | +657.58% | 27 | Apr 10, 2025 | |
| ABSI Absci | Reiterates: Buy | $9 | $2.75 | +227.27% | 3 | Apr 9, 2025 | |
| ARTV Artiva Biotherapeutics | Reiterates: Buy | $23 | $2.08 | +1,005.77% | 5 | Apr 8, 2025 | |
| FATE Fate Therapeutics | Reiterates: Hold | n/a | $1.04 | - | 6 | Mar 6, 2025 | |
| ACLX Arcellx | Reiterates: Buy | $105 | $57.55 | +82.45% | 23 | Dec 10, 2024 | |
| GBIO Generation Bio Co. | Reiterates: Buy | $8 | $0.36 | +2,122.22% | 17 | May 8, 2025 | |
| SRPT Sarepta Therapeutics | Maintains: Buy | $183 → $125 | $36.27 | +244.64% | 31 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $8 | $4.33 | +84.76% | 23 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $27 | $9.50 | +184.21% | 24 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $2.13 | +181.69% | 26 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $71 | $28.40 | +150.00% | 14 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $42 | $6.99 | +500.86% | 20 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $2.41 | +190.46% | 17 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $1.93 | +469.95% | 16 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.27 | +608.66% | 7 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $0.88 | +354.55% | 13 | Apr 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $0.95 | - | 16 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.18 | +323.73% | 22 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $5.99 | - | 6 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $0.45 | +796.86% | 9 | Aug 2, 2024 |
Cartesian Therapeutics
May 8, 2025
Maintains: Buy
Price Target: $41 → $40
Current: $9.91
Upside: +303.84%
CRISPR Therapeutics AG
May 7, 2025
Maintains: Buy
Price Target: $84 → $81
Current: $35.62
Upside: +127.40%
Celcuity
Apr 11, 2025
Reiterates: Buy
Price Target: $29
Current: $10.15
Upside: +185.71%
Autolus Therapeutics
Apr 10, 2025
Reiterates: Buy
Price Target: $10
Current: $1.32
Upside: +657.58%
Absci
Apr 9, 2025
Reiterates: Buy
Price Target: $9
Current: $2.75
Upside: +227.27%
Artiva Biotherapeutics
Apr 8, 2025
Reiterates: Buy
Price Target: $23
Current: $2.08
Upside: +1,005.77%
Fate Therapeutics
Mar 6, 2025
Reiterates: Hold
Price Target: n/a
Current: $1.04
Upside: -
Arcellx
Dec 10, 2024
Reiterates: Buy
Price Target: $105
Current: $57.55
Upside: +82.45%
Generation Bio Co.
May 8, 2025
Reiterates: Buy
Price Target: $8
Current: $0.36
Upside: +2,122.22%
Sarepta Therapeutics
May 7, 2025
Maintains: Buy
Price Target: $183 → $125
Current: $36.27
Upside: +244.64%
May 6, 2025
Maintains: Buy
Price Target: $11 → $8
Current: $4.33
Upside: +84.76%
Apr 29, 2025
Reiterates: Buy
Price Target: $27
Current: $9.50
Upside: +184.21%
Apr 10, 2025
Reiterates: Buy
Price Target: $6
Current: $2.13
Upside: +181.69%
Apr 10, 2025
Reiterates: Buy
Price Target: $71
Current: $28.40
Upside: +150.00%
Apr 9, 2025
Reiterates: Buy
Price Target: $42
Current: $6.99
Upside: +500.86%
Apr 9, 2025
Reiterates: Buy
Price Target: $7
Current: $2.41
Upside: +190.46%
Apr 9, 2025
Reiterates: Buy
Price Target: $11
Current: $1.93
Upside: +469.95%
Apr 8, 2025
Reiterates: Buy
Price Target: $9
Current: $1.27
Upside: +608.66%
Apr 4, 2025
Reiterates: Buy
Price Target: $4
Current: $0.88
Upside: +354.55%
Mar 27, 2025
Reiterates: Hold
Price Target: n/a
Current: $0.95
Upside: -
Mar 12, 2025
Reiterates: Buy
Price Target: $5
Current: $1.18
Upside: +323.73%
Feb 20, 2025
Reiterates: Hold
Price Target: n/a
Current: $5.99
Upside: -
Aug 2, 2024
Reiterates: Buy
Price Target: $4
Current: $0.45
Upside: +796.86%